Demographic and Clinical Characteristics of Patients Who Underwent Thyroidectomy in Southern Population of Iran Based on Iranian National Thyroid Surgery Registry (INTSR)

Karajizadeh, M; Taheri Akerdi, A; Yousefi, MR; Jafari, F; Mughani Nasab, A; Deilami, I; Paydar, Sh

Demographic and Clinical Characteristics of Patients Who Underwent Thyroidectomy in Southern Population of Iran Based on Iranian National Thyroid Surgery Registry (INTSR)

Authors

M Karajizadeh ¹

A Taheri Akerdi ²

MR Yousefi ³

F Jafari ⁴

A Mughani Nasab ⁵

I Deilami ⁶

Sh Paydar ⁷

¹ Assistant Professor of Health Information Management, Trauma Research Center, Shiraz University of Medical Sciences

² Assistant Professor, Department of Surgery, Trauma Research Center, Shiraz University of Medical Sciences

³ General practitioner,Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

⁴ Assistant Professor, Department of Pathology, Faculty of Medicine, Shiraz University of Medical Sciences

⁵ General Surgeon, Faculty of Medicine, Shiraz University of Medical Sciences, Kowsar Hospital

⁶ General Surgeon, Faculty of Medicine, Shiraz University of Medical Sciences, Faghihi Hospital

⁷ Professor, Department of General Surgery, Trauma Research Center, Shiraz University of Medical Sciences

Abstract

Background and Objective: Thyroid malignancy is a fairly common cancer which had an increasing rate of incidence in the recent years. This disease presents itself as nodular lesions. Thyroidectomy is a standard procedure for managing patients with thyroid malignancies. This disease is also prevalent in the population of southern Iran and makes up the majority of the endocrine malignancies. Due to the importance of the disease, in this study we aimed evaluate the demographic and clinical characteristics of patients who underwent thyroidectomy in southern population of Iran. Materials & Methods: This cross-sectional study uses the data extracted from Iranian National Thyroid Surgery Registry (INTSR). All the patients who underwent thyroidectomy during 2023 and 2024 and did not fulfill any exclusion criteria are enrolled in the study. Demographic data, medical history, familial history, laboratory data, and details of their surgery are extracted and evaluated. Results: Of all the 1409 patients in the study, 274 (19.4%) were males and 1135 (80.6%) were females. The mean age of the patients was 44.33±12.96. the most common surgery was total thyroidectomy (13.7 (92.8%0). The most common pathologic findings after surgery were PTC classic type (32.2%), MNG (19.7%), PTC follicular type (17.7%), PTMC (15.1%), benign nodular hyperplasia (14.7%), Hashimoto (2.6%), parathyroid adenoma (2.4%), graves’ disease (1.8%), Hurthle cell carcinoma (1.4%), and MTC (0.7%), respectively. The most common FNA findings were as follows: PTC (43.9%), benign findings (17.1%), AUS/FLUS (7.9%), MNG (7.9%), and graves’ disease (2.3%), respectively. Conclusion: In this study, the demographic and clinical data of patients who underwent thyroidectomy is evaluated. PTC was seen to be the most prevalent pathology among the patients. The majority of patients who underwent thyroidectomy were women. The most common FNA result was also PTC. Further studies are required to deepen our understanding of risk-factors and predisposing factors of thyroid malignancies and improve the treatment quality.

Keywords

Thyroid Surgery

Thyroid cancer

epidemiology

Thyroid Nodules

1. Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013; 23(7): 885-91.

2. Society AC. Cancer Facts & Figures 2024. Atlanta: American Cancer Society; 2024.

3. Balajam NZ, Mousavian A-H, Sheidaei A,
Gohari K, Tavangar SM, Ghanbari-Motlagh A, et al. The 15-year national trends of endocrine
cancers incidence among Iranian men and women; 2005–2020. Scientific Reports. 2023; 13(1): 7632.

4. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low-risk tumours. Bmj. 2013; 347: f4706.

5. Udelsman R, Zhang Y. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid.
2014; 24(3): 472-9.

6. Haugen BR. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed? Cancer. 2017; 123(3): 372-81.

7. Hong S, Xie Y, Cheng Z, Li J, He W, Guo Z, et al. Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability. Oncogene. 2022; 41(47): 5121-32.

8. Hu J, Yuan IJ, Mirshahidi S, Simental A, Lee SC, Yuan X. Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy. Int J Mol Sci. 2021; 22(4).

9. Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, et al. The natural
history of benign thyroid nodules. Jama. 2015; 313(9): 926-35.

10. Grussendorf M, Ruschenburg I, Brabant G. Malignancy rates in thyroid nodules: a long-term cohort study of 17,592 patients. Eur Thyroid J. 2022; 11(4).

11. Zamora EA KS, Cassaro S. Thyroid Nodule. treasure island (fl): StatPearls Publishing; 2023.

12. Giuffrida D, Giuffrida R, Puliafito I, Vella V, Memeo L, Puglisi C, et al. Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer. Int J Surg Oncol. 2019; 2019: 2715260.

13. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26(1): 1-133.

14. Back K, Lee J, Cho A, Choe J-H, Kim J-H, Oh YL, et al. Is total thyroidectomy with bilateral central neck dissection the only surgery for papillary thyroid carcinoma patients with clinically involved central nodes? BMC Surgery. 2022; 22(1): 251.

15. Dismukes J, Fazendin J, Obiarinze R, Márquez GCH, Ramonell KM, Buczek E, et al. Prophylactic Central Neck Dissection in Papillary Thyroid Carcinoma: All Risks, No Reward. J Surg Res. 2021; 264: 230-5.

16. Xu V, Renslo B, Cottrill EE. Central Neck Dissection: Updates on Indications and Surgical Technique. Operative Techniques in
Otolaryngology-Head and Neck Surgery. 2024.

17. Akbari M AK, Khayamzadeh M, Tabatabaee M, Esnaashari F, Motlagh A. Iran cancer report. Shahid Beheshti University of Medical Sciences, Tehran: Cancer Research Center; 2008.

18. Hadavandsiri F, Allahqoli L, Rahimi Y, Salehiniya H, Ghazanfari Savadkoohi E, Akbari ME. Cancer incidence in Iran in 2016: A study based on the Iranian National Cancer Registry. Cancer Rep (Hoboken). 2024; 7(2): e1967.

19. Salari N, Kazeminia M, Mohammadi M. The Prevalence of Thyroid Cancer in Iran: a Systematic Review and Meta-analysis. Indian J Surg Oncol. 2022; 13(1): 225-34.

20. Rezaianzadeh A, Ghoddusi Johari M, Niazkar HR, Khosravizadegan Z, Monabati A, Shiraziyeganeh B. Cancer incidence in Southern Iran, 2015-2018: A population-based study on cancer registry profile of Fars province. Health Sci Rep. 2023; 6(6): e1333.

21. 21. Najafizadeh-Sari S, Khosravi MH, Mohebbi H. Indications and Immediate Post-surgical Complications of Thyroidectomy; An Experience from Baqiyatallah University Hospital, Tehran, Iran. Canon Journal of Medicine. 2019; 1(1): 27-30.

22. Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. Jama. 2021; 326(16): 1614-21.

23. LeClair K, Bell KJL, Furuya-Kanamori L, Doi SA, Francis DO, Davies L. Evaluation of Gender Inequity in Thyroid Cancer Diagnosis: Differences by Sex in US Thyroid Cancer Incidence Compared with a Meta-analysis of Subclinical Thyroid Cancer Rates at Autopsy. JAMA Intern Med. 2021; 181(10): 1351-8.

24. Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol. 2010; 6(11): 1771-9.

25. Tran Q-L, Davies L. Thyroid Cancer Incidence Differences between Men and Women. Current Opinion in Endocrine and Metabolic Research. 2023; 31: 100472.

26. Machens A, Hauptmann S, Dralle H. Disparities between male and female patients with thyroid cancers: sex difference or gender divide? Clinical endocrinology. 2006; 65(4): 500-5.

27. M. M. AT Aruldhas SKB, P. Govindarajulu. Thyroidal concentration of testosterone and estradiol determines the promotion of thyroid tumours in
N-nitrosodiisopropanolamine (DHPN) treated Wistar rats. 12^th Asia Pacific Cancer Conference: Towards Total Cancer Control; Singapore 2023. p. 43.

28. Rajoria S, Suriano R, George AL, Shanmugam A, Jussim C, Shin EJ, et al. Estrogen activity as a preventive and therapeutic target in thyroid cancer. Biomed Pharmacother. 2012; 66(2): 151-8.

29. Li LR, Song JL, Liu HQ, Chen C. Hypertension Was Associated with Higher Tumor Stages in
Papillary Thyroid Cancer: A Large Sample
Single-Center Study. Metab Syndr Relat Disord. 2022; 20(8): 466-72.

30. Dong WW, Zhang DL, Wang ZH, Lv CZ, Zhang P, Zhang H. Different types of diabetes mellitus and risk of thyroid cancer: A meta-analysis of cohort studies. Front Endocrinol (Lausanne). 2022; 13: 971213.

31. Wu R, Zhang J, Zou G, Li S, Wang J, Li X, et al. Diabetes Mellitus and Thyroid Cancers: Risky Correlation, Underlying Mechanisms and Clinical Prevention. Diabetes Metab Syndr Obes.
2024; 17: 809-23.

32. Coca-Pelaz A, Rodrigo JP, Shah JP, Nixon IJ, Hartl DM, Robbins KT, et al. Recurrent Differentiated Thyroid Cancer: The Current Treatment Options. Cancers (Basel). 2023; 15(10).

33. Ywata de Carvalho A, Kohler HF, Gomes CC, Vartanian JG, Kowalski LP. Predictive factors for recurrence of papillary thyroid carcinoma: analysis of 4,085 patients. Acta Otorhinolaryngol Ital.
2021; 41(3): 236-42.

34. Li S, Ren C, Gong Y, Ye F, Tang Y, Xu J, et al. The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients with Differentiated Thyroid Cancer. Front Endocrinol (Lausanne). 2022; 13: 872527.

35. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007; 246(3): 375-81; discussion 81-4.

36. Nixon I. The Surgical Approach to Differentiated

Thyroid Cancer. F1000Res. 2015; 4.

37. Kuczma P, Demarchi MS, Leboulleux S, Trésallet C, Mavromati M, Djafarrian R, et al. Central node dissection in papillary thyroid carcinoma in the era of near-infrared fluorescence. Front Endocrinol (Lausanne). 2023; 14: 1110489.

38. Moo TA, McGill J, Allendorf J, Lee J, Fahey T, 3rd, Zarnegar R. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg. 2010; 34(6): 1187-91.

39. Shen WT, Ogawa L, Ruan D, Suh I, Kebebew E, Duh Q-Y, et al. Central Neck Lymph Node Dissection for Papillary Thyroid Cancer: Comparison of Complication and Recurrence Rates in 295 Initial Dissections and Reoperations. Archives of Surgery. 2010; 145(3): 272-5.

40. Limaiem F RA, Mazzoni T. Papillary Thyroid Carcinoma. Treasure Island (FL): StatPearls; 2024.

41. Vu-Phan D, Koenig RJ. Genetics and epigenetics of sporadic thyroid cancer. Molecular and Cellular Endocrinology. 2014; 386(1): 55-66.

42. Kovatcheva, R. D., Shinkov, A. D., Dimitrova, I. D., Ivanova, R. B., Vidinov, K. N., & Ivanova,
R. S. (2021). Evaluation of the Diagnostic Performance of EU-TIRADS in Discriminating Benign from Malignant Thyroid Nodules: A Prospective Study in One Referral Center. European Thyroid Journal, 9(6), 304-312. Retrieved Oct 15, 2024, from https://doi.org/10.1159/000507575.

43. Dy, J. G., Kasala, R., Yao, C., Ongoco, R., & Mojica, D. J. (2017). Thyroid Imaging Reporting and Data System (TIRADS) in Stratifying Risk of Thyroid Malignancy at the Medical City. Journal of the ASEAN Federation of Endocrine Societies, 32(2),
108-116. https://doi.org/10.15605/jafes.032.02.03.

44. Tom James Cawood, Georgia Rose Mackay, Penny Jane Hunt, Donal O’Shea, Stephen Skehan,
Yi Ma, TIRADS Management Guidelines in the Investigation of Thyroid Nodules; Illustrating the Concerns, Costs, and Performance, Journal of the Endocrine Society, Volume 4, Issue 4, April 2020, bvaa031, https://doi.org/10.1210/jendso/bvaa031.